重症监护病房老年非心原性危重症患者B型利钠肽水平与预后的关系

被引：1

作者：

张国强 ^{[1
,2
]}

陶永康 ^{[2
]}

练睿 ^{[2
]}

杨健萍 ^{[2
]}

高文 ^{[2
]}

张志 ^{[2
]}

张素巧 ^{[2
]}

赵水平 ^{[1
]}

机构：

[1] 中南大学湘雅二医院心内科

[2] 中日友好医院急诊科

来源：

中华老年医学杂志 | 2010年 / 12期

关键词：

利钠肽,脑; 危重病; 预后;

D O I：

暂无

中图分类号：

R686 [筋腱、韧带、滑囊疾病及损伤];

学科分类号：

摘要：

目的探讨急诊重症监护病房(EICU)中B型利钠肽(BNP)对老年非心原性危重症患者28 d病死率的预测价值。方法连续选取EICU老年非心原性危重症患者70例,收集临床资料,检测BNP水平并随访患者28 d内是否死亡。结果 28 d内共有22例(31.4%)患者死亡,死亡组BNP水平的自然对数值明显高于存活组,分别为(6.4±1.2)ng/L与(5.1±1.5)ng/L(P<0.05),BNP预测EICU老年危重症患者28 d病死率所得出接收者操作特征曲线下面积为0.759(95%可信区间0.636～0.882,P<0.05),BNP预测EICU老年危重症患者28 d病死率最佳临界点为342 ng/L,敏感度为77.3%,特异度为68.7%,Youden指数为0.460。结论 BNP可作为预测老年非心原性危重症患者28 d病死率方便快捷的预测指标。

引用

共 10 条

[1] PROGNOSTIC IMPORTANCE OF INCREASED PLASMA AMINO-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE LEVELS IN A LARGE NONCARDIAC, GENERAL INTENSIVE CARE UNIT POPULATION[J] . Anastasia Kotanidou,Petros Karsaliakos,Marinella Tzanela,Irini Mavrou,Petros Kopterides,Evangelos Papadomichelakis,Maria Theodorakopoulou,Efi Botoula,Iraklis Tsangaris,Michalis Lignos,Ignatios Ikonomidis,Ioannis Ilias,Apostolos Armaganidis,Stylianos E. Orfanos,Ioanna Dimopoulou.Shock . 2009 (4)
[2] Diagnostic and prognostic impact of brain natriuretic peptide in cardiac and noncardiac diseases
Zakynthinos, Epaminondas
Kiropoulos, Theodoros
Gourgoulianis, Konstantinos
Filippatos, Gerasimos
[J]. HEART & LUNG, 2008, 37 (04): : 275 - 285
[3] Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions
Burke, Michael A.
Cotts, William G.
[J]. HEART FAILURE REVIEWS, 2007, 12 (01) : 23 - 36
[4] B-type natriuretic peptide: Issues for the intensivist and pulmonologist
Jason, Phua
Keang, Lim Tow
Hoe, Lee Kang
[J]. CRITICAL CARE MEDICINE, 2005, 33 (09) : 2094 - 2103
[5] Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes
Tomaru, K
Arai, M
Yokoyama, T
Aihara, Y
Sekiguchi, K
Tanaka, T
Nagai, R
Kurabayashi, M
[J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (06) : 649 - 659
[6] Cardiac chamber-specific alterations of ANP and BNP expression with advancing age and with systemic hypertension[J] . V. Raizada,K. Thakore,W. Luo,P.G. Mcguire.Molecular and Cellular Biochemistry . 2001 (1)
[7] Interleukin-1β Regulates the Human Brain Natriuretic Peptide Promoter via Ca2-Dependent Protein Kinase Pathways[J] . Quan He,Margot C. LaPointe.Hypertension: Journal of the American Heart Association . 2000 (1, P)
[8] Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro
Kuwahara, K
Saito, Y
Harada, M
Ishikawa, M
Ogawa, E
Miyamoto, Y
Hamanaka, I
Kamitani, S
Kajiyama, N
Takahashi, N
Nakagawa, O
Masuda, I
Nakao, K
[J]. CIRCULATION, 1999, 100 (10) : 1116 - 1124
[9] Interleukin-1 beta Regulation of the Human Brain Natriuretic Peptide Promoter Involves Ras-, Rac-, and p38 Kinase-Dependent Pathways in Cardiac Myocytes[J] . Quan He,Margot LaPointe.Hypertension . 1999 (1S S)
[10] Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
Cowie, MR
Struthers, AD
Wood, DA
Coats, AJS
Thompson, SG
PooleWilson, PA
Sutton, GC
[J]. LANCET, 1997, 350 (9088) : 1349 - 1353

← 1 →